Regulation of the Epithelial-Mesenchymal Transition by Claudin-3 and Claudin-4

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Lin, Xinjian ^a   Shang, Xiying ^a   Manorek, Gerald ^a   Howell, Stephen B ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLAUDIN 3; CLAUDIN 4; MESSENGER RNA; NERVE CELL ADHESION MOLECULE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE; PROTEIN KINASE B; TRANSCRIPTION FACTOR TWIST; UVOMORULIN; VIMENTIN; CADHERIN; PHOSPHATIDYLINOSITOL 3,4,5-TRIPHOSPHATE; POLYPHOSPHOINOSITIDE; TWIST RELATED PROTEIN 1;

ARTICLE; CANCER CELL; CELL INVASION; CELL MIGRATION; CELL SIZE; CELL SPREADING; CELL STRUCTURE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; GENE OVEREXPRESSION; GENE REPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; IN VIVO STUDY; MOUSE; NONHUMAN; OVARY CANCER; PROTEIN DEPLETION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TUMOR GROWTH; UPREGULATION; ANIMAL; ANTAGONISTS AND INHIBITORS; BAGG ALBINO MOUSE; CELL MOTION; GENETICS; METABOLISM; NUDE MOUSE; RNA INTERFERENCE; TUMOR CELL LINE;

ANIMALS; CADHERINS; CELL LINE, TUMOR; CELL MOVEMENT; CLAUDIN-3; CLAUDIN-4; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; HUMANS; MICE; MICE, INBRED BALB C; MICE, NUDE; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHATIDYLINOSITOL PHOSPHATES; PROTO-ONCOGENE PROTEINS C-AKT; RNA INTERFERENCE; RNA, MESSENGER; SIGNAL TRANSDUCTION; TWIST-RELATED PROTEIN 1; UP-REGULATION;

EID: 84879252752     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0067496     Document Type: Article

References (75)

1. Braga VM, (2002) Cell-cell adhesion and signalling. Curr Opin Cell Biol 14: 546-556.
2. Thiery JP, (2002) Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2: 442-454.
3. Acloque H, Adams MS, Fishwick K, Bronner-Fraser M, Nieto MA, (2009) Epithelial-mesenchymal transitions: the importance of changing cell state in development and disease. J Clin Invest 119: 1438-1449.
4. Thiery JP, Acloque H, Huang RY, Nieto MA, (2009) Epithelial-mesenchymal transitions in development and disease. Cell 139: 871-890.
5. Iwanicki MP, Davidowitz rA, Ng MR, Besser A, Muranen T, et al. (2011) Ovarian Cancer Spheroids Use Myosin-Generated Force to Clear the Mesothelium. Cancer Discovery.
6. Sawada N, Murata M, Kikuchi K, Osanai M, Tobioka H, et al. (2003) Tight junctions and human diseases. Med Electron Microsc 36: 147-156.
7. Wittekind C, Neid M, (2005) Cancer invasion and metastasis. Oncology 69Suppl 1: 14-16.
8. Ouban A, Ahmed AA, (2010) Claudins in human cancer: a review. Histol Histopathol 25: 83-90.
9. Mineta K, Yamamoto Y, Yamazaki Y, Tanaka H, Tada Y, et al. (2011) Predicted expansion of the claudin multigene family. FEBS Lett 585: 606-612.
10. Szasz AM, Nemeth Z, Gyorffy B, Micsinai M, Krenacs T, et al. (2011) Identification of a claudin-4 and E-cadherin score to predict prognosis in breast cancer. Cancer Sci 102: 2248-2254.
11. Hennessy BT, Gonzalez-Angulo AM, Stemke-Hale K, Gilcrease MZ, Krishnamurthy S, et al. (2009) Characterization of a naturally occurring breast cancer subset enriched in epithelial-to-mesenchymal transition and stem cell characteristics. Cancer Res 69: 4116-4124.
12. Prat A, Parker JS, Karginova O, Fan C, Livasy C, et al. (2010) Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer. Breast Cancer Res 12: R68.
13. Tsutsumi K, Sato N, Tanabe R, Mizumoto K, Morimatsu K, et al. (2012) Claudin-4 expression predicts survival in pancreatic ductal adenocarcinoma. Ann Surg Oncol 19Suppl 3: 491-499.
14. Ersoz S, Mungan S, Cobanoglu U, Turgutalp H, Ozoran Y, (2011) Prognostic importance of Claudin-1 and Claudin-4 expression in colon carcinomas. Pathol Res Pract 207: 285-289.
15. Matsuoka T, Mitomi H, Fukui N, Kanazawa H, Saito T, et al. (2011) Cluster analysis of claudin-1 and-4, E-cadherin, and beta-catenin expression in colorectal cancers. J Surg Oncol 103: 674-686.
16. Cheng TC, Manorek G, Samimi G, Lin X, Berry CC, et al. (2006) Identification of genes whose expression is associated with cisplatin resistance in human ovarian carcinoma cells. Cancer Chemother Pharmacol 58: 384-395.
17. Hough CD, Sherman-Baust CA, Pizer ES, Montz FJ, Im DD, et al. (2000) Large-scale serial analysis of gene expression reveals genes differentially expressed in ovarian cancer. Cancer Res 60: 6281-6287.
18. Lu KH, Patterson AP, Wang L, Marquez RT, Atkinson EN, et al. (2004) Selection of potential markers for epithelial ovarian cancer with gene expression arrays and recursive descent partition analysis. Clin Cancer Res 10: 3291-3300.
19. Tassi RA, Bignotti E, Falchetti M, Ravanini M, Calza S, et al. (2008) Claudin-7 expression in human epithelial ovarian cancer. Int J Gynecol Cancer 18: 1262-1271.
20. Bignotti E, Tassi RA, Calza S, Ravaggi A, Romani C, et al. (2006) Differential gene expression profiles between tumor biopsies and short-term primary cultures of ovarian serous carcinomas: identification of novel molecular biomarkers for early diagnosis and therapy. Gynecol Oncol 103: 405-416.
21. Heinzelmann-Schwarz VA, Gardiner-Garden M, Henshall SM, Scurry J, Scolyer RA, et al. (2004) Overexpression of the cell adhesion molecules DDR1, Claudin 3, and Ep-CAM in metaplastic ovarian epithelium and ovarian cancer. Clin Cancer Res 10: 4427-4436.
22. Choi YL, Kim J, Kwon MJ, Choi JS, Kim TJ, et al. (2007) Expression profile of tight junction protein claudin 3 and claudin 4 in ovarian serous adenocarcinoma with prognostic correlation. Histol Histopathol 22: 1185-1195.
23. Finch A, Shaw P, Rosen B, Murphy J, Narod SA, et al. (2006) Clinical and pathologic findings of prophylactic salpingo-oophorectomies in 159 BRCA1 and BRCA2 carriers. Gynecol Oncol 100: 58-64.
24. Karst AM, Levanon K, Drapkin R, (2011) Modeling high-grade serous ovarian carcinogenesis from the fallopian tube. Proc Natl Acad Sci U S A 108: 7547-7552.
25. Lee Y, Miron A, Drapkin R, Nucci MR, Medeiros F, et al. (2007) A candidate precursor to serous carcinoma that originates in the distal fallopian tube. J Pathol 211: 26-35.
26. Levanon K, Ng V, Piao HY, Zhang Y, Chang MC, et al. (2010) Primary ex vivo cultures of human fallopian tube epithelium as a model for serous ovarian carcinogenesis. Oncogene 29: 1103-1113.
27. Shang X, Lin X, Alvarez E, Manorek G, Howell SB, (2012) Tight junction proteins claudin-3 and claudin-4 control tumor growth and metastases. Neoplasia 14: 974-985.
28. Shang X, Lin X, Manorek G, Howell SB (2012) Claudin-3 and Claudin-4 Regulate Sensitivity to Cisplatin by Controlling Expression of the Copper and Cisplatin Influx Rransporter CTR1. Mol Pharmacol.
29. Davidson B, Trope CG, Reich R, (2012) Epithelial-mesenchymal transition in ovarian carcinoma. Front Oncol 2: 33.
30. Disaia PJ, Sinkovics JG, Rutledge FN, Smith JP, (1972) Cell-mediated immunity to human malignant cells. Am J Obstet Gynecol 114: 979-989.
31. Selby PJ, Thomas JM, Monaghan P, Sloane J, Peckham MJ, (1980) Human tumour xenografts established and serially transplanted in mice immunologically deprived by thymectomy, cytosine arabinoside and whole-body irradiation. Br J Cancer 41: 52-61.
32. Yuan X, Lin X, Manorek G, Kanatani I, Cheung LH, et al. (2009) Recombinant CPE fused to tumor necrosis factor targets human ovarian cancer cells expressing the claudin-3 and claudin-4 receptors. Mol Cancer Ther 8: 1906-1915.
33. Miranda KC, Khromykh T, Christy P, Le TL, Gottardi CJ, et al. (2001) A dileucine motif targets E-cadherin to the basolateral cell surface in Madin-Darby canine kidney and LLC-PK1 epithelial cells. J Biol Chem 276: 22565-22572.
34. Agarwal R, D'Souza T, Morin PJ, (2005) Claudin-3 and claudin-4 expression in ovarian epithelial cells enhances invasion and is associated with increased matrix metalloproteinase-2 activity. Cancer Res 65: 7378-7385.
35. Huber MA, Kraut N, Beug H, (2005) Molecular requirements for epithelial-mesenchymal transition during tumor progression. Curr Opin Cell Biol 17: 548-558.
36. Yang J, Weinberg RA, (2008) Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. Dev Cell 14: 818-829.
37. Larue L, Bellacosa A, (2005) Epithelial-mesenchymal transition in development and cancer: role of phosphatidylinositol 3' kinase/AKT pathways. Oncogene 24: 7443-7454.
38. Wang Y, Sheng Q, Spillman MA, Behbakht K, Gu H, (2012) Gab2 regulates the migratory behaviors and E-cadherin expression via activation of the PI3K pathway in ovarian cancer cells. Oncogene 31: 2512-2520.
39. Matter K, Balda MS, (2003) Signalling to and from tight junctions. Nat Rev Mol Cell Biol 4: 225-236.
40. Schneeberger EE, Lynch RD, (2004) The tight junction: a multifunctional complex. Am J Physiol Cell Physiol 286: C1213-1228.
41. Langbein L, Pape UF, Grund C, Kuhn C, Praetzel S, et al. (2003) Tight junction-related structures in the absence of a lumen: occludin, claudins and tight junction plaque proteins in densely packed cell formations of stratified epithelia and squamous cell carcinomas. Eur J Cell Biol 82: 385-400.
42. Martin TA, Jiang WG, (2001) Tight junctions and their role in cancer metastasis. Histol Histopathol 16: 1183-1195.
43. Itoh M, Bissell MJ, (2003) The organization of tight junctions in epithelia: implications for mammary gland biology and breast tumorigenesis. J Mammary Gland Biol Neoplasia 8: 449-462.
44. Mullin JM, (2004) Epithelial barriers, compartmentation, and cancer. Sci STKE 2004: pe2.
45. Hurd TW, Gao L, Roh MH, Macara IG, Margolis B, (2003) Direct interaction of two polarity complexes implicated in epithelial tight junction assembly. Nat Cell Biol 5: 137-142.
46. Kohler K, Zahraoui A, (2005) Tight junction: a co-ordinator of cell signalling and membrane trafficking. Biol Cell 97: 659-665.
47. Martin TA, Watkins G, Mansel RE, Jiang WG, (2004) Loss of tight junction plaque molecules in breast cancer tissues is associated with a poor prognosis in patients with breast cancer. Eur J Cancer 40: 2717-2725.
48. Hudson LG, Zeineldin R, Stack MS, (2008) Phenotypic plasticity of neoplastic ovarian epithelium: unique cadherin profiles in tumor progression. Clin Exp Metastasis 25: 643-655.
49. Rangel LB, Agarwal R, D'Souza T, Pizer ES, Alo PL, et al. (2003) Tight junction proteins claudin-3 and claudin-4 are frequently overexpressed in ovarian cancer but not in ovarian cystadenomas. Clin Cancer Res 9: 2567-2575.
50. Santin AD, Zhan F, Bellone S, Palmieri M, Cane S, et al. (2004) Gene expression profiles in primary ovarian serous papillary tumors and normal ovarian epithelium: identification of candidate molecular markers for ovarian cancer diagnosis and therapy. Int J Cancer 112: 14-25.
51. Hibbs K, Skubitz KM, Pambuccian SE, Casey RC, Burleson KM, et al. (2004) Differential gene expression in ovarian carcinoma: identification of potential biomarkers. Am J Pathol 165: 397-414.
52. Lal-Nag M, Morin PJ, (2009) The claudins. Genome Biol 10: 235.
53. Hewitt KJ, Agarwal R, Morin PJ, (2006) The claudin gene family: expression in normal and neoplastic tissues. BMC Cancer 6: 186.
54. Senga K, Mostov KE, Mitaka T, Miyajima A, Tanimizu N, (2012) Grainyhead-like 2 regulates epithelial morphogenesis by establishing functional tight junctions through the organization of a molecular network among claudin3, claudin4, and Rab25. Mol Biol Cell 23: 2845-2855.
55. Klymkowsky MW, Savagner P, (2009) Epithelial-mesenchymal transition: a cancer researcher's conceptual friend and foe. Am J Pathol 174: 1588-1593.
56. Polyak K, Weinberg RA, (2009) Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat Rev Cancer 9: 265-273.
57. Yilmaz M, Christofori G, (2009) EMT, the cytoskeleton, and cancer cell invasion. Cancer Metastasis Rev 28: 15-33.
58. Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, et al. (2008) The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133: 704-715.
59. Yoshida J, Horiuchi A, Kikuchi N, Hayashi A, Osada R, et al. (2009) Changes in the expression of E-cadherin repressors, Snail, Slug, SIP1, and Twist, in the development and progression of ovarian carcinoma: the important role of Snail in ovarian tumorigenesis and progression. Med Mol Morphol 42: 82-91.
60. Veatch AL, Carson LF, Ramakrishnan S, (1994) Differential expression of the cell-cell adhesion molecule E-cadherin in ascites and solid human ovarian tumor cells. Int J Cancer 58: 393-399.
61. Yuecheng Y, Hongmei L, Xiaoyan X, (2006) Clinical evaluation of E-cadherin expression and its regulation mechanism in epithelial ovarian cancer. Clin Exp Metastasis 23: 65-74.
62. Buick RN, Pullano R, Trent JM, (1985) Comparative properties of five human ovarian adenocarcinoma cell lines. Cancer Res 45: 3668-3676.
63. Kalluri R, Weinberg RA, (2009) The basics of epithelial-mesenchymal transition. J Clin Invest 119: 1420-1428.
64. Zeisberg M, Neilson EG, (2009) Biomarkers for epithelial-mesenchymal transitions. J Clin Invest 119: 1429-1437.
65. Rodriguez FJ, Lewis-Tuffin LJ, Anastasiadis PZ, (2012) E-cadherin's dark side: Possible role in tumor progression. Biochim Biophys Acta 1826: 23-31.
66. Onder TT, Gupta PB, Mani SA, Yang J, Lander ES, et al. (2008) Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways. Cancer Res 68: 3645-3654.
67. Conacci-Sorrell M, Simcha I, Ben-Yedidia T, Blechman J, Savagner P, et al. (2003) Autoregulation of E-cadherin expression by cadherin-cadherin interactions: the roles of beta-catenin signaling, Slug, and MAPK. J Cell Biol 163: 847-857.
68. Franco HL, Casasnovas J, Rodriguez-Medina JR, Cadilla CL, (2011) Redundant or separate entities?--roles of Twist1 and Twist2 as molecular switches during gene transcription. Nucleic Acids Res 39: 1177-1186.
69. Nieto MA, (2002) The snail superfamily of zinc-finger transcription factors. Nat Rev Mol Cell Biol 3: 155-166.
70. Comijn J, Berx G, Vermassen P, Verschueren K, van Grunsven L, et al. (2001) The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion. Mol Cell 7: 1267-1278.
71. Yang J, Mani SA, Donaher JL, Ramaswamy S, Itzykson RA, et al. (2004) Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 117: 927-939.
72. Karreth F, Tuveson DA, (2004) Twist induces an epithelial-mesenchymal transition to facilitate tumor metastasis. Cancer Biol Ther 3: 1058-1059.
73. Vesuna F, van Diest P, Chen JH, Raman V, (2008) Twist is a transcriptional repressor of E-cadherin gene expression in breast cancer. Biochem Biophys Res Commun 367: 235-241.
74. Wang H, Quah SY, Dong JM, Manser E, Tang JP, et al. (2007) PRL-3 down-regulates PTEN expression and signals through PI3K to promote epithelial-mesenchymal transition. Cancer Res 67: 2922-2926.
75. Grille SJ, Bellacosa A, Upson J, Klein-Szanto AJ, van Roy F, et al. (2003) The protein kinase Akt induces epithelial mesenchymal transition and promotes enhanced motility and invasiveness of squamous cell carcinoma lines. Cancer Res 63: 2172-2178.